| Terje Ahlquist | |
| Position: | Post doc |
| Phone: | +47 2278 1731 |
| Email: | |

Publications by Terje Ahlquist
11 publications found
Publications 2010
-
Tumor spreading to the contralateral ovary in bilateral ovarian carcinoma is a late event in clonal evolution
J Oncol, 2010, 646340
PubMed 19759843 -
Genomic aberrations in borderline ovarian tumors
J Transl Med, 8, 21
PubMed 20184781
Publications 2009
-
New doctorial cancer research:novel genetic and epigenetic alterations in colorectal tumors and their potential as biomarkers
Crit Rev Oncog, 15 (1), 81-3
PubMed 20092436 -
Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours
J Pathol, 217 (5), 693-701
PubMed 19142971 -
Autophagy in tumour suppression and promotion
Mol Oncol, 3 (4), 366-75
PubMed 19559660
Publications 2008
-
RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A
Neoplasia, 10 (7), 680-6, 2 p following 686
PubMed 18592002 -
Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers
Mol Cancer, 7, 94
PubMed 19117505 -
Hypermethylated MAL gene - a silent marker of early colon tumorigenesis
J Transl Med, 6, 13
PubMed 18346269
Publications 2007
-
DNA hypermethylation of MAL: a promising diagnostic biomarker for colorectal tumors
Gastroenterology, 132 (4), 1631-2; author reply 1632
PubMed 17408629 -
Slip slidin' away: a duodecennial review of targeted genes in mismatch repair deficient colorectal cancer
Crit Rev Oncog, 13 (3), 229-57
PubMed 18298386 -
DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets
Mol Cancer, 6, 45
PubMed 17623056
Academic theses:
Ahlquist T (2009) "Novel Genetic and Epigenetic Alterations In Colorectal Tumors and Their Potential as Biomarkers". A thesis for the PhD degree. The Medical Faculty, University of Oslo
Ahlquist T (2004) "Genetic and epigenetic markers in precursor lesions of colorectal cancer".- A thesis for the Cand. scient. degree. Division of Cell Biology, Department of Molecular Biosciences, The Faculty of Mathematics and Natural Sciences, University of Oslo.
Supervisor experience
Co-supervisor for Master of Science student Ellen Christine Røyrvik from The Faculty of Mathematics and Natural Sciences, University of Oslo. 2006-2007. “Slip Slidin' Away: Mutations in colorectal cancer with microsatellite instability”.
Department of Cancer Prevention, Institute for Cancer Research, Rikshospitalet Medical Centre, N-0310 Oslo, Norway.
Publications 2010
Tumor spreading to the contralateral ovary in bilateral ovarian carcinoma is a late event in clonal evolution
J Oncol, 2010, 646340
PubMed 19759843
Genomic aberrations in borderline ovarian tumors
J Transl Med, 8, 21
PubMed 20184781
Publications 2009
New doctorial cancer research:novel genetic and epigenetic alterations in colorectal tumors and their potential as biomarkers
Crit Rev Oncog, 15 (1), 81-3
PubMed 20092436
Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours
J Pathol, 217 (5), 693-701
PubMed 19142971
Autophagy in tumour suppression and promotion
Mol Oncol, 3 (4), 366-75
PubMed 19559660
Publications 2008
RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A
Neoplasia, 10 (7), 680-6, 2 p following 686
PubMed 18592002
Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers
Mol Cancer, 7, 94
PubMed 19117505
Hypermethylated MAL gene - a silent marker of early colon tumorigenesis
J Transl Med, 6, 13
PubMed 18346269
Publications 2007
DNA hypermethylation of MAL: a promising diagnostic biomarker for colorectal tumors
Gastroenterology, 132 (4), 1631-2; author reply 1632
PubMed 17408629
Slip slidin' away: a duodecennial review of targeted genes in mismatch repair deficient colorectal cancer
Crit Rev Oncog, 13 (3), 229-57
PubMed 18298386
DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets
Mol Cancer, 6, 45
PubMed 17623056




Go back
Print this page
E-mail this page
